A viral nanoparticle with dual function as an anthrax antitoxin and vaccine - Wikidata - wikimedia - TriplyDB

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

http://www.wikidata.org/entity/Q28469319

about

CryoEM visualization of an adenovirus capsid-incorporated HIV antigen Virus-Based Nanoparticles as Versatile Nanomachines Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents Subviral particle as vaccine and vaccine platform.Norovirus P particle, a novel platform for vaccine development and antibody production.In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli.Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.Structural analysis and insertion study reveal the ideal sites for surface displaying foreign peptides on a betanodavirus-like particle.A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.Polyvalent complexes for vaccine development Recent insights into the biology and biomedical applications of Flock House virus Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Engineered viral nanoparticles for flow cytometry and fluorescence microscopy applications.Newly discovered insect RNA viruses in China.Anthrax vaccines: present status and future prospects.Bioengineering virus-like particles as vaccines.Nodavirus-based biological container for targeted delivery system.The application of virus-like particles as vaccines and biological vehicles.Nanoparticles and DNA - a powerful and growing functional combination in bionanotechnology.SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure.Altering the landscape of viruses and bionanoparticles.Adjuvant formulations for virus-like particle (VLP) based vaccines.Advances in the study of nodavirus.Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies.Low endocytic pH and capsid protein autocleavage are critical components of Flock House virus cell entry The RNA Capping Enzyme Domain in Protein A is Essential for Flock House Virus Replication

P2860

Q27335395-807A25FB-E91E-466C-89B2-9A9CB11060B4 Q28068538-A993990D-F72C-4C92-A1FD-2D5D7A9BC74D Q28384852-9BD59F5A-C956-463E-8F89-937D412A9079 Q33812653-1A644CA4-6509-464A-A74B-E849151628A2 Q34485266-0FCDB351-F891-4067-A86E-D00A971AB99B Q34861411-135C0298-FCAA-4ADE-9F88-3C5419C36273 Q36136393-F6A04799-2BCC-425C-806F-6D222C339343 Q36363177-3680D6D9-097A-435A-8959-A4E4BABFB1EC Q36445296-226CA569-35AB-419E-896C-66BE4D1F31B1 Q36454704-39CD1A77-453B-45CF-896F-5EF7BCBDBCD4 Q36630332-1FB0DE5A-E516-4ADF-BAC9-723B9D6F8678 Q36792270-F6274B27-B9F1-4EB4-B55E-B6B3EB4B0308 Q36877226-01F83B07-9341-4620-B25E-0BF3AF89CEEA Q37262118-5673E5AD-A77D-4A70-8FAD-4D2672595B1C Q37792984-34A0C6EF-6B70-4292-B3C3-7A9AAC2BB9FA Q38018887-6600BADF-7483-4E8C-8631-1D4DD92A2513 Q38126812-2C7AB16A-3F5E-4E0B-9BAE-B1947BB9C18D Q38132268-1CA52946-DE37-48B4-8560-2A4A74DF3B8E Q38172045-92BF5520-EF66-4275-8405-CF3C5CF234DB Q38192663-7DC7F7CF-5F08-4536-BE8E-AD79735305FF Q38603912-FA80D650-CC3D-470F-BAEC-E6712C5F7814 Q38808906-22DD5C61-5E2A-4F58-8CA9-0A68B7CE0A55 Q39118758-C434D9CD-5659-4AE0-AAD9-19512CCB3CF7 Q39729448-EF4C9D0B-849F-44F9-9B44-BB284FD886E4 Q40093469-29465747-56AD-45D2-AC9B-D44B7291109A Q41925816-20F4A0C1-003A-4ECA-AEDE-34655E1544AF Q41973374-1AFDF345-500B-4F30-8343-91889A3FE404 Q42017332-23C60ABB-53DB-4859-8A56-5C066412AFF0 Q42092014-34CE8B4D-A9AA-405A-8EFC-41F4925F54DE Q58756887-F14E2467-850E-4615-BBA7-4FC0ED1AF1B0

P2860

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

http://www.wikidata.org/entity/Q28469319

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@ast

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@en

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@nl

type

label

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@ast

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@en

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@nl

prefLabel

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@ast

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@en

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@nl

P1433

Q28469319-C0F58761-A17B-4993-A5FB-16BABA4F7355

P1476

Q28469319-8C1C9BDA-27B1-412D-BD97-5CF31B04AF7D

P2093

Q28469319-2324D621-EE00-4FCF-A642-C53D3F79546D

Q28469319-619EAE3B-04A4-4860-A4C9-7464A7B50263

Q28469319-794F3917-4674-4415-AD09-7CBE061E2751

Q28469319-7FCFDEF2-5C99-4697-8B54-DCC1AD3F1835

Q28469319-8D12E9F4-994D-415E-81A7-DEF63460CBFE

Q28469319-92F6E014-ED1A-4F4C-A482-B3C834987F69

Q28469319-9A833EA1-D449-425A-B160-245548853C25

Q28469319-A6413B38-91DC-4BE1-B4C4-56E9662699B3

Q28469319-A94783CA-AE6E-46B4-8157-2F03600F3A62

Q28469319-C1C85D36-8487-4B89-BB85-7C8ABA2F6F7A

P2860

Q28469319-07C00C53-D3FD-4AC8-992E-617CE2458842

Q28469319-083AA809-DD2B-4F85-BA41-9840805D5AA6

Q28469319-0B5329FD-1287-4917-B4C8-B8A12FA71809

Q28469319-0B9B5CD4-BE1D-4C60-BF06-A4A673D0452E

Q28469319-187A31E1-4931-4D2D-B64F-42EF3CBA1A01

Q28469319-2535A9BD-261D-45BC-9C34-283D855C0D43

Q28469319-25EAFF1A-3D18-4908-AFC1-5AB93AF0DF92

Q28469319-29F86C3C-09D8-4C96-974B-2E84EB4DB4F6

Q28469319-2A1269D5-5998-4A9B-8CCA-D22B3AD04146

Q28469319-2C08E57C-DFB7-4DC9-8EC7-7F21D3B290A2

P304

Q28469319-C40C3423-BF0F-4AD4-A6B1-E0E5A4A36379

P31

Q28469319-442FF795-C06A-40EF-ADEB-6A1FFB87968A

P356

Q28469319-B1C6215F-9C69-4227-ABE4-C04131E7CA36

P407

Q28469319-AB0F5A41-96DF-4799-B4C0-662F6CDA0F9B

P433

Q28469319-FF61AFF9-50FE-4693-907D-1B60094DE941

P478

Q28469319-6578D1AA-6D5E-42CC-B00D-627A7F11F7B3

P50

Q28469319-3ECC8EC0-F50E-4CE9-8654-94996318D79C

P577

Q28469319-F349ED40-B4B5-4E3E-9D8C-42A5FAEDD99F

P5875

Q28469319-26E39423-EA7E-489B-AE1F-7242D28E2AC1

P698

Q28469319-250294BD-F9A1-4CB2-A919-0F907460638A

P921

Q28469319-681F2245-CB83-4472-8183-517A17A13F8C

P932

Q28469319-59477EA2-AF71-4B10-9E67-D84A6EF488C2

P356

JOURNAL.PPAT.0030142

P1433

P1476

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

@en

P2093

Anette Schneemann

http://www.w3.org/2001/XMLSchema#string

Darly J Manayani

http://www.w3.org/2001/XMLSchema#string

Diane Thomas

http://www.w3.org/2001/XMLSchema#string

G Jonah A Rainey

http://www.w3.org/2001/XMLSchema#string

Heather M Scobie

http://www.w3.org/2001/XMLSchema#string

John A T Young

http://www.w3.org/2001/XMLSchema#string

John M Marlett

http://www.w3.org/2001/XMLSchema#string

Kelly A Dryden

http://www.w3.org/2001/XMLSchema#string

Marc E Siladi

http://www.w3.org/2001/XMLSchema#string

Mark Yeager

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a complex between anthrax toxin and its host cell receptor

Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation

The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin

Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen

Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

Improved methods for building protein models in electron density maps and the location of errors in these models

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin

Capsid protein synthesis from replicating RNA directs specific packaging of the genome of a multipartite, positive-strand RNA virus.

P304

1422-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.0030142

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Marianne Manchester

P577

2007-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5921641

http://www.w3.org/2001/XMLSchema#string

P698

17922572

http://www.w3.org/2001/XMLSchema#string

P921

P932

2000967

http://www.w3.org/2001/XMLSchema#string